
Regeneron Pharmaceuticals Inc. Faces Securities Law Violation Lawsuit – Investors Urged to Contact Levi & Korsinsky for Details (REGN)
Regeneron Pharmaceuticals Faces Class Action Securities Lawsuit Investors Beware: SEC Alleges Securities Fraud New York – February 11, 2025 Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely…